Skip to main content
. 2022 Sep 15;40(1):47–76. doi: 10.1007/s11095-022-03385-w

Table III.

Active Targeting of Different Immune Cell Types

Receptor Ligand Delivery System Type of nucleic acid Key results Reference
Macrophages
Mannose receptor Mannose PLL polyplexes DNA Transfection to monocyte-derived macrophages using Man-PLL polyplexes [151]
Mannose

PLL polyplexes

and

pAsp(DET) polyplexes

DNA 8× increased transfection efficacy for Man-PLL polyplexes, 500× increased transfection efficacy for Man-pAsp(DET) polyplexes in murine bone marrow derived macrophages [152]
CM Mannose Direct conjugate siRNA Ligand-dependent gene silencing in monocyte-derived macrophages (in vitro) and in splenic and liver macrophages (in vivo) [61]
Mannose Cationic nano-hydrogel siRNA Receptor-dependent delivery of siRNA to M2 macrophages and efficient gene knockdown in primary cells and in mice [153, 154]
Dendritic cells
Mannose receptor Mannose PEI polyplexes pDNA Increase of transfection efficacy by mannosylation of PEI polyplexes, uptake was reduced in presence of the inhibitor Mannose-BSA [82]
Mannose PEGylated LNPs mRNA Variation of PEG-spacer length (PEG100, PEG1000 and PEG2000) was evaluated; LNPs with Man-PEG1000 showed highest transfection efficacy [156]
CMM Direct conjugate siRNA Ligand-dependent gene silencing activity in monocyte derived DCs [61]
Mannan LNP Self-amplifying RNA Enhanced immunization was observed for LNPs decorated with multivalent mannose residues [157]
DEC205 Anti-DEC205 scFv LNP siRNA DEC205-dependency on uptake was demonstrated; targeted LNPs showed twofold increase in uptake compared to untargeted LNPs and LNPs with an isotype of scFv [160]
T-lymphocytes
CD3 T-cell receptor Anti-CD3 antibodies PLL polyplexes pDNA 1000-fold enhanced gene expression compared to unmodified PLL and Tf-PLL in T-cells; successful transfection to primary human lymphocytes [58]
CD4 Anti-CD4 mAb LNP siRNA Specific delivery to CD4+ cells ex vivo; gene silencing activity was observed in blood, bone marrow, spleen and lymph nodes [59]
Ly6c Anti-Ly6-mAb LNP mmRNA Targeted delivery to Ly6c positive cells in vitro; in vivo evaluation in IBD mouse model showed increased protein expression [20-fold in intestine, tenfold in spleen]; expression of anti-inflammatory IL-10 after delivery of IL-10 encoding mmRNA [164, 165]
n.a None (chemical targeting) LNP Barcode siRNA, sgRNA

Screening of 168 different LNP formulations in vivo with variations of head group, lipid alkyl chains, phospholipid and molar composition;

adamantyl-DSPC delivered siRNA and sgRNA to T cells (and Kupffer cells)

[166]
n.a None (chemical targeting) LNP siRNA Variation of head group and alkyl chain; piperazine headgroup led to accumulation and gene silencing in the spleen [167]
Integrin β7 Anti-β7-mAb LNP siRNA CD45 mRNA silencing in CD4+ and CD8+ T cells in spleen and lymph nodes [167]

Abbreviations: PLL, Poly-L-lysine; Man, Mannose; pAsp(DET) poly(N-[N-[2-aminoethyl]-2-aminoethyl] aspartamide); CM Mannose, chemically modified mannose; PEI, polyethylene imine; BSA, bovine serum albumin; DCs, dendritic cells; scFv, single chain antibody; CD, cluster of differentiation; Tf, Transferrin; mAb, monoclonal antibody; Ly6c, lymphocyte antigen 6 complex; mmRNA, modified messenger RNA; IBD, inflammatory bowel disease; mAb, monoclonal antibody